Distinction between serous tumors of low malignant potential and serous carcinomas based on global mRNA expression profiling
- 1 March 2005
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 96 (3) , 684-694
- https://doi.org/10.1016/j.ygyno.2004.11.039
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Ovarian Serous Tumors of Low Malignant Potential (Borderline Tumors)The American Journal of Surgical Pathology, 2005
- Mutations in BRAF and KRAS Characterize the Development of Low-Grade Ovarian Serous CarcinomaJNCI Journal of the National Cancer Institute, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Behavior of Borderline Tumors With Particular Interest to Persistence, Recurrence, and Progression to Invasive Carcinoma: A Prospective StudyJournal of Clinical Oncology, 2001
- Histopathology of familial ovarian tumors in women from families with and without germline BRCA1 mutationsHuman Pathology, 2000
- Microsatellite Analysis in Serous Tumors of the OvaryInternational Journal of Gynecological Pathology, 1999
- Comparison of Mutations of Ki-RAS and p53 Immunoreactivity in Borderline and Malignant Epithelial Ovarian TumorsThe American Journal of Surgical Pathology, 1999
- In serous ovarian neoplasms the frequency of Ki-ras mutations correlates with their malignant potentialVirchows Archiv, 1999
- Tumor Recurrence in Stage I Ovarian Serous Neoplasms of Low Malignant PotentialInternational Journal of Gynecological Pathology, 1998
- Classification and Staging of Malignant Tumours in the Female PelvisActa Obstetricia et Gynecologica Scandinavica, 1971